Chemistry: molecular biology and microbiology – Enzyme – proenzyme; compositions thereof; process for... – Hydrolase
Patent
1997-08-27
1998-10-27
Prouty, Rebecca E.
Chemistry: molecular biology and microbiology
Enzyme , proenzyme; compositions thereof; process for...
Hydrolase
4353201, 4352523, 43525411, 435325, 536 232, C12N 926, C12N 1500, C12N 500, C07H 2104
Patent
active
058277218
ABSTRACT:
The invention features a purified hyaluronidase BH55 polypeptide isolated from a mammalian species, preferably bovine or human. The invention also features DNA encoding BH55, vectors and transformed host cells containing DNA encoding BH55, methods of making BH55 hyaluronidase polypeptides, and antibodies that specifically bind BH55.
REFERENCES:
patent: 4179337 (1979-12-01), Davis et al.
patent: 4800159 (1989-01-01), Mullis et al.
patent: 4820516 (1989-04-01), Sawyer et al.
patent: 5166322 (1992-11-01), Shaw et al.
patent: 5206344 (1993-04-01), Katre et al.
Dorfman et al., "A turbidimetric method for the assay of hyaluronidase," 1948, J. Biol. Chem. 172:367-375.
Reissig et al., "A modified colorimetric method for the estimation of N-acetylamino sugars," 1955 J. Biol. Chem. 217:959-966.
Ozello et al., "Growth-promoting activity of acid mucopolysaccharides on a strain of human mammary carcinoma cells," 1960 Cancer Res. 20:600-604.
Takeuchi et al., "Variation in glycosaminoglycan components of breast tumors," 1976 Cancer Res. 36:2133-2139.
Pawlowski et al., "The effects of hyalurodinase upon tumor formation in Balb c Mice Painted with 7.12-Dimethylbenz-(.alpha.)Anthracene,," 1979, Int. J. Cancer 23;105-109; Abstract 415, (1981) Proceedings 22:105.
Tengblad, "Affinity Chromatography on immmobilized hyaluronate and its application to the isolation of hyaluronate binding proteins from cartilage," 1979, Biochim. Biophys. Acta 578:281-289.
Kimata et al., "Increased Synthesis of Hyaluronic Acid by Mouse Mammary Carcinoma Cell Variants with High Metastic Potential", 1983, Cancer Res. 43:1347-1354.
Doctor et al., "Isolation and Properties of a New Anticoagulant Protein From Commercial Bovine Testicular Hyaluronidase", 1983 Thrombosis Research 30:565-571.
Baumgartner et al., "Hyaluronidase in Combination with Anticancer Drugs--Results of a Pilot Study", 1985, Wiener Klinische Wochenscrift 97:148-153.
Horn et al., "Intraversical Chemotherapy of Superficial Bladder Tumors in a Controlled Trial with Cis-Platinum Versus Cis-Platinum Plus Hyaluronidase," 1985, Journal of Surgical Oncology 28:304-307.
Barnhart, publ. 1985, PDR 39.sup.th Ed., Medical Economics Company, Inc., Ordell, NJ, pp. 2296-2297.
Zanker et al., "Introduction of Response in Previous Chemotherapy Resistant Patients by Hyaluronidase," 1986, Proceedings of AACR 27:390, Abstract No. 1550.
Baumgartner, Hyaluronidase in Management of Malignant Diseases, 1987, Deilage zu Wien Klin Wochenschr 99 by Springer-Verlag/Wien, pp. 3-22.
Baumgartner et al., "Phase I Study in Chemoresistant Logo-regional malignant disease with Hyaluronidase," 1988, Reg. Cancer Treat. 1:55-58.
Scheithauer et al., In Vitro Evalutation of the Anticancer Drug Modulatory Effect of Hyaluronidase in Human Gastrointestinal Cell Lines, 1988, Anticancer Research 8:391-396.
Baumgartner et al., "Hyaluronidase--an Effective Substance in the Treatment of Malignant Disease," 1988 5.sup.th Medical Department with Oncology, Vienna City Hospital Lainz, pp. 3-9.
Czejka et al., 1990, Pharmazie 45:H.9.
Lace et al., "The Effects of Deglycosylation on the Properties of Native and Biotinylated Bovine Testicular Hyaluronidase," 1990, Carbohydrate Research 208:306-311.
Nucci et al., "The Therapeutic Value of Poly(ethylene glycol)-Modified Proteins," 1991 Adv. Drug Delivery Rev. 4:133-151.
Clark-Lewis et al., "Chemical Synthesis, Purification, and Characterization of Two Inflammatory Proteins, Neutrophil Activating Peptide 1 (Interleukin-8) and Neutrophil Activating Peptide 2," 1991, Biochemistry 30:3128-3135.
Schuller et al., "Pharmacokinetics of Intrahepatic 5-Fluorouracil .+-. Preinjected Hyaluronidase (Neopermease, N)," 1991, Amer. Assoc. For Cancer Res. 32:171, Abstract No. 1034.
Bertrand et al., "Hyaluronan (Hyaluronic Acid) and Hyaluronectin in the Extracellular Matrix of Human Breast Carcinomas: Comparison Between Invasive and Non-Invasive Area," 1991, Int. J. Cancer 52:1-6.
Underhill, "CD44: The Hyaluronan Receptor," 1992, J. Cell Science 103:293-298.
Gunthert et al., "A New Variant of Glycoprotein CD44 Confers Metastic Potential to Rat Carcinoma Cells," 1991, Cell 65:13-24.
De Maeyer et al., "The Growth Rate of Two Transplantable Murine Tumors, 3LL Lung Carcinoma and B16F10 Melanoma, is Influenced by Hyal-1, A Locus Determining Hyaluronidase Levels and Ploymorphism," 1992 Int. J. Cancer 51:657-660.
Beckenlehner et al., "Hyaluronidase Enhances the Activity of Adriamycin in Breast Cancer Models In Vitro and In Vivo," 1992, J. Cancer Res. Clin. Oncol. 118: 591-596.
Stern et al., "An ELISA-Like Assay for Hyaluronidase and Hyaluronidase Inhibitors," 1992, Matrix 12:397-403.
Guntenhoner et al., "A Substrate-Gel Assay for Hyaluronidase Activity," 1992, Matrix 12:388-396.
Lin et al., "Molecular Cloning of the Human and Monkey Sperm Surface Protein PH-20," 1993, Proc. Natl. Acad. Sci. USA 90:10071-10075.
Knudson et al., "Hyaluronan-Binding Proteins in Development, Tissue Homeostasis, and Disease," 1993 FASEB J. 7:1233-1241.
Wielenga et al., "Expression of CD44 Variant Proteins in Human Colorectal Cancer is Related to Tumor Progression," 1993, Cancer Research 53:4754-4756.
Joensuu et al., "Glycoprotein CD44 Expression and its Association with Survival in Breast Cancer," 1993, American Journal of Pathology 143(3):867-874.
Bartolazzi et al., "Interaction Betweeen CD44 and Hyaluronate is Directly Implicated in the Regulation of Tumor Development," 1994, J. Exp. Med., The Rockefeller University Press 180:53-66.
Zhu et al., "molecular Cloning of Mammalian Hyaluronidase Reveals Identity with Hemopexin, a Serum Heme-binding Protein," 1994, J. of Biol. Chem. 269(51):32092-32097.
Yokozaki et al., "Expression of CD44 Abnormal Transcripts in Human Gastric Carcinomas," 1994, Cancer Letters 83:229-234.
Kohno et al., "Effects of Hyaluronidase on Doxorubicin Penetration into Squamous Carcinoma Multicellular Tumor Spheroids and its Cell Lethality," 1994, J. Cancer Res. Clin. Oncol. 120:293-297.
Arky, Consult., 1994, PDR 48.sup.th Ed., medical Economics Data Production Co. Montrale, NJ, pp. 2626-2627.
Frost et al., "A Novel Hyaluronidase Isolated from Bovine Testes," 1995, FASEB, ASBMB/DBC-ACS 9(6), Abstract.
Colbern Gail T.
Formby Bent
Frost Gregory I.
Hall Jackson
Shuster Svetlana
Francis Carol L.
Hobbs Lisa J.
Prouty Rebecca E.
The Regents of the University of California
LandOfFree
BH55 hyaluronidase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with BH55 hyaluronidase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BH55 hyaluronidase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1613223